Even if a formal demonstration is still missing, these effects are likely mediated through the up-regulation of MYC, as also supported by the involvement of a NOTCH1-MYC axis in the glycolytic switch induced in CLL cells by stromal cells, an event contributing to stroma-mediated chemoresistance (60). The gene discussed is MYC; the disease is B-cell chronic lymphocytic leukemia.